Sure, it's an improvement on Stribild, but it still has cobi and the associated side-effects. There is still a marketing angle here - why have a ritonavir-like booster for an inferior integrase when there is a better integrase that's QD unboosted and all you need to do is get over your fears of Epzicom to have one-pill-once-a-day.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.